<DOC>
	<DOCNO>NCT01181466</DOCNO>
	<brief_summary>The purpose study assess procedural post-procedural safety efficacy AeriSeal therapy 4 subsegments single treatment session patient GOLD Stage III/IV homogeneous heterogeneous emphysema .</brief_summary>
	<brief_title>AeriSealÂ® System Lung Volume Reduction Patients With Advanced Emphysema</brief_title>
	<detailed_description>Emphysema progressive , debilitate disease characterize destruction lung tissue result inflammation cause exposure noxious inhaled agent extend period . The common cause condition cigarette smoking , although genetic , occupational , environmental cause account 10 % case . Despite aggressive public health initiative aim discourage use cigarette , smoking-related lung disease remain significant cause disability death worldwide . Due number current new smoker , emphysema expect remain leading cause morbidity mortality year come . The AeriSeal System novel device system develop treatment advanced emphysema . The AeriSeal System administer bronchoscopically , design provide physiological benefit lung volume reduction without risk cost major surgery .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Patients must diagnosis advanced emphysema define FEV1/FVC &lt; 70 % predict , FEV1 &lt; 50 % predict , TLC &gt; 100 % predict , RV &gt; 135 % predict . Patients must persistent symptom despite medical therapy either candidate Lung Volume Reduction Surgery ( LVRS ) elect undergo LVRS . Patients must &gt; 40 year age , symptom despite medical therapy , none prespecified comorbid condition could influence study outcome ability tolerate bronchoscopy .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>PLVR</keyword>
	<keyword>BLVR</keyword>
	<keyword>AeriSeal</keyword>
	<keyword>treatment</keyword>
	<keyword>device</keyword>
	<keyword>breathing</keyword>
	<keyword>COPD</keyword>
	<keyword>emphysema</keyword>
	<keyword>polymeric lung volume reduction</keyword>
	<keyword>biologic lung volume reduction</keyword>
	<keyword>heterogeneous</keyword>
	<keyword>homogeneous</keyword>
	<keyword>Pathologic Processes</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
</DOC>